Hui Michelle M, Clement Colin I
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Eye Associates, Sydney, New South Wales, Australia.
J Curr Glaucoma Pract. 2018 Sep-Dec;12(3):107-112. doi: 10.5005/jp-journals-10028-1254.
This study aims to evaluate the early to the midterm efficacy of deep sclerectomy (DS) without an intra-scleral spacer for open-angle glaucoma (OAG) patients.
Retrospective study of 99 eyes (88 patients) with open-angle glaucoma who underwent DS were recruited in a consecutive order following informed consent. Intraocular pressure (IOP) was collected up to 60 months post operation (mean 19.87 ± 15.13 months). Criteria of success were defined as the qualified success (QS) or complete success (CS) with IOP level less than 21, 18 and 15 mm Hg and a reduction of more than 20% IOP from baseline. QS includes additional medication post-DS, while CS requires no other medications or surgery post-DS. Further analysis includes comparing the criteria of success based on several factors. The data were analyzed using statistical package for social sciences (SPSS version 21) statistical software.
The QS at 60 months for IOP less than 21, 18 and 15 mm Hg is 71.3% (45.12 ± 2.46), 63.9% (40.41 ± 2.75) and 48.7% (35.62 ± 2.85), respectively. The CS at 60 months for IOP less than 21, 18 and 15 mm Hg are 69.3% (47.51 ± 2.77), 57.9% (40.41 ± 2.75) and 45.2% (35.62 ± 2.85), respectively. There was no significant difference between QS and DS post-DS based on the level of experience of the surgeons; intraoperation complication; age and gender. There was a significant reduction in IOP post operation ( < 0.001).
DS is observed to be an effective surgical method with a favorable safety profile to manage patients with open-angle glaucoma. It has a better safety profile compared to trabeculectomy (TE) and can be performed by surgeons of different experience safely and successfully.
To our knowledge, this is the first report of DS in an Australian population with up to 60 months of follow-up. It is an effective procedure for IOP control in patients with OAG and has fewer complications compared to TE. DS is less popular than TE primarily due to a perceived steep learning curve, but most of the literature on DS describe single surgeon results. Our study compared the outcome of five surgeons with a variety of experience and found no significant differences in the rate of success for all levels of IOP.
Hui MM, Clement CI. Evaluation of the Early to Mid-term Efficacy and Safety of Deep Sclerectomy without an Intrascleral Spacer for Open-angle Glaucoma in an Australian Population. J Curr Glaucoma Pract 2018;12(3):107-112.
本研究旨在评估无巩膜内间隔物的深层巩膜切除术(DS)治疗开角型青光眼(OAG)患者的早期至中期疗效。
对99只眼(88例患者)行DS的开角型青光眼患者进行回顾性研究,患者均在签署知情同意书后依次入选。收集术后60个月内的眼压(IOP)数据(平均19.87±15.13个月)。成功标准定义为眼压水平低于21、18和15mmHg且眼压较基线降低超过20%的合格成功(QS)或完全成功(CS)。QS包括DS术后额外用药,而CS要求DS术后无需其他药物或手术。进一步分析包括根据多个因素比较成功标准。使用社会科学统计软件包(SPSS 21版)统计软件对数据进行分析。
60个月时,眼压低于21、18和15mmHg的QS分别为71.3%(45.12±2.46)、63.9%(40.41±2.75)和48.7%(35.62±2.85)。60个月时,眼压低于21、18和15mmHg的CS分别为69.3%(47.51±2.77)、57.9%(40.41±2.75)和45.2%(35.62±2.85)。基于外科医生的经验水平、术中并发症、年龄和性别,DS术后QS和CS之间无显著差异。术后眼压有显著降低(<0.001)。
观察到DS是治疗开角型青光眼患者的一种有效手术方法,安全性良好。与小梁切除术(TE)相比,它具有更好的安全性,不同经验的外科医生均可安全、成功地实施。
据我们所知,这是澳大利亚人群中对DS进行长达60个月随访的首份报告。它是控制OAG患者眼压的有效方法,与TE相比并发症更少。DS不如TE普及主要是因为其学习曲线较陡,但大多数关于DS的文献描述的是单一外科医生的数据。我们的研究比较了五位经验各异的外科医生的结果,发现不同眼压水平的成功率无显著差异。
许美美,克莱门特·CI。澳大利亚人群中无巩膜内间隔物的深层巩膜切除术治疗开角型青光眼的早期至中期疗效及安全性评估。《当代青光眼实践杂志》2018;12(3):107 - 112。